Emmessar Biotech & Nutrition informs about disclosure

04 Sep 2023 Evaluate
In terms of Regulation 34 of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulation, 2011, Emmessar Biotech & Nutrition has informed that Mathurakavi Srinivasa Raghavan Ayyangar, Chief Promoter, have acquired 5026 equity shares of the company between August 30 & August 31, 2023, through open market. It has enclosed the disclosure under Regulation, 29(2) of the SEBI (SAST) Regulation 2011.

The above information is a part of company’s filings submitted to BSE.

Emmessar Biotech&Nut Share Price

41.84 -0.06 (-0.14%)
28-May-2024 15:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1464.85
Dr. Reddys Lab 5955.65
Cipla 1477.15
Zydus Lifesciences 1050.35
Lupin 1603.55
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.